![Targeting those left behind in Zimbabwe’s HIV response: A call for decriminalisation of key populations to rapidly achieve 95-95-95 targets](https://icap.columbia.edu/wp-content/uploads/51138037313_eb75755b4b_o-e1623766668770-1080x675.jpg)
HIV
![Targeting those left behind in Zimbabwe’s HIV response: A call for decriminalisation of key populations to rapidly achieve 95-95-95 targets](https://icap.columbia.edu/wp-content/uploads/51138037313_eb75755b4b_o-e1623766668770-1080x675.jpg)
![Improving Child Tuberculosis Contact Identification and Screening in Lesotho: Results From a Mixed-Methods Cluster-Randomized Implementation Science Study](https://icap.columbia.edu/wp-content/uploads/0-3-e1622128820264-1-1080x675.png)
Improving Child Tuberculosis Contact Identification and Screening in Lesotho: Results From a Mixed-Methods Cluster-Randomized Implementation Science Study
Hirsch-Moverman, Yael, et al. “Improving Child Tuberculosis Contact Identification and Screening in Lesotho: Results from a Mixed-Methods Cluster-Randomized Implementation Science Study.” PLOS ONE, vol. 16, no. 5, 2021, doi:10.1371/journal.pone.0248516. Abstract...![Improving Services for HIV-Exposed Infants in Zambia and Cameroon Using a Quality Improvement Collaborative Approach](https://icap.columbia.edu/wp-content/uploads/3249657868_0f7f6540a5_o-rotated-e1623165101211-1080x675.jpg)
Improving Services for HIV-Exposed Infants in Zambia and Cameroon Using a Quality Improvement Collaborative Approach
Dougherty, Gillian, et al. “Improving Services for HIV-Exposed Infants in Zambia and Cameroon Using a Quality Improvement Collaborative Approach.” Global Health: Science and Practice, 2021, doi:10.9745/ghsp-d-20-00550. Abstract Introduction: Early infant diagnosis...![May 2021: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis](https://icap.columbia.edu/wp-content/uploads/0-3-e1622128820264-1080x675.png)
May 2021: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Article: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis Published in: N Engl J Med. 2021;384(18):1705-1718. https://www.nejm.org/doi/full/10.1056/NEJMoa2033400 Authors: Dorman SE, Nahid P, Kurbatova EV, et al. Summary: The Tuberculosis...![Isoniazid preventive therapy use among adult people living with HIV in Zimbabwe](https://icap.columbia.edu/wp-content/uploads/GettyImages-480659301-e1620922662571-1080x675.jpg)